Invenomic Capital Management LP

BOSTON, MA · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 16, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$2.04B2026 Q3+ $272.2K options (notional, not included)
Positions117
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.29.2%

Invenomic Capital Management LP reported 117 positions worth $2.04B as of September 30, 2026 (13F filed November 16, 2026). Largest holding: UHS (3.9%). Biggest move: new buy AMTM ($66.7M).

10 / 117 positions shown
#SymbolCompanyValue ↓% Port.Shares1YYTDSince reported
▸ 1 UHSUniversal Health Services$79.6M3.91%456,662——+13.5%
▸ 2 GPNGlobal Payments$68.2M3.35%835,167——+10.0%
▸ 3 AMTMAmentum$66.7M3.28%3,683,718——+18.5%
▸ 4 STSensata Technologies$62.1M3.05%1,493,441——-10.3%
▸ 5 GDDYGoDaddy$56.6M2.78%592,670——+17.5%
▸ 6 OMCOmnicom$55.0M2.70%747,200——+19.5%
▸ 7 FISFidelity National Information$54.2M2.66%1,648,002——-14.0%
▸ 8 CHTRCharter Communications$51.8M2.54%467,348——+25.3%
▸ 9 PVHPVH$50.1M2.46%676,078——+26.0%
▸ 10 SPSCSPS Commerce$49.7M2.44%602,292——-0.9%

Pro Feature

The remaining 107 positions with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

Frequently Asked Questions

What stocks does Invenomic Capital Management LP hold as of Q3 2026?

Invenomic Capital Management LP reported 117 positions worth $2.04B in its Q3 2026 13F filing. Largest positions: UHS (3.9%), GPN (3.3%), AMTM (3.3%), ST (3.0%) and GDDY (2.8%).

What did Invenomic Capital Management LP buy in Q3 2026?

New positions: AMTM, GDDY, OCTV, RRX and EFOR (37 in all). Added to: ST, SFM, GEHC, KBR and CHTR (46 in all).

What did Invenomic Capital Management LP sell in Q3 2026?

Reduced: WDAY, CRM, SPSC, FISV and EGO (30 in all). Sold out entirely: BDX, BILL, PATH, FIVN and HAE (36 in all).

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.